FDA — authorised 14 November 2001
- Application: BLA103950
- Marketing authorisation holder: BIOVITRUM AB
- Local brand name: KINERET
- Indication: VIAL — SUBCUTANEOUS
- Status: approved
🇺🇸 Kineret in United States
FDA authorised Kineret on 14 November 2001
Marketing authorisation
Kineret in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in United States
Frequently asked questions
Is Kineret approved in United States?
Yes. FDA authorised it on 14 November 2001.
Who is the marketing authorisation holder for Kineret in United States?
BIOVITRUM AB holds the US marketing authorisation.